Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety Image Number 13 for United States Patent #8119616. The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.       Recently Added Patents Data encoding and decoding apparatus and method thereof for verifying data integrity Formation of a masking layer on a dielectric region to facilitate formation of a capping layer on electrically conductive regions separated by the dielectric region Protecting information written to recording medium Communication apparatus, and method and program for controlling same Golf club cover Liquid crystal display device Methods and systems for use in tracking targets for direction finding systems   Randomly Featured Patents Method and apparatus for simulating standard test wafers Highly scalable network environment for managing remote devices Liquid crystal display device Dual path memory retrieval system for an interleaved dynamic RAM memory unit Control system for a vehicle/implement hitch Universal variable length code (UVLC) encoder Latent mercaptans as multi-functional additives for halogen-containing polymer compositions Salt water aquarium integrated filter Novel triazafluoranthene compound and processes for preparing the same Content addressable memory (CAM) devices that support background BIST and BISR operations and methods of operating same © 2006-2008 PatentGenius. All Rights Reserved.